Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia

This publication has 33 references indexed in Scilit:

• Lovastatin Therapy in Hypercholesterolemia: Effect on Fibrinogen, Hemorrheologic Parameters, Platelet Activity, and Red Blood Cell Morphology
  The Journal of Clinical Pharmacology, 1991
• Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with α-tocopheryl nicotinate
  Atherosclerosis, 1990
• Proline-rich protein is a glycoprotein and an acute phase reactant
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
• Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients
  Atherosclerosis, 1988
• Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
• Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
  New England Journal of Medicine, 1984
• Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)
  Atherosclerosis, 1982
• Fibrinogen catabolism in patients with type II and type IV hyperlipidemia. Effect of dietary and clofibrate treatment on laboratory findings.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981
• Clinical and metabolic effects of pentaerythritol tetranicotinate (perycit®) and a comparison with plain nicotinic acid
  Atherosclerosis, 1974
• Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe
  Klinische Wochenschrift, 1966